Cross-Presentation of the Oncofetal Tumor Antigen 5T4 from Irradiated Prostate Cancer Cells--A Key Role for Heat-Shock Protein 70 and Receptor CD91.
Josephine Salimu, Lisa K Spary, Saly Al-Taei, Aled Clayton, Malcolm D Mason, John Staffurth, Zsuzsanna Tabi
Index: Cancer. Immunol. Res. 3 , 678-88, (2015)
Full Text: HTML
Abstract
Immune responses contribute to the success of radiotherapy of solid tumors; however, the mechanism of triggering CD8(+) T-cell responses is poorly understood. Antigen cross-presentation from tumor cells by dendritic cells (DC) is a likely dominant mechanism to achieve CD8(+) T-cell stimulation. We established a cross-presentation model in which DCs present a naturally expressed oncofetal tumor antigen (5T4) from irradiated DU145 prostate cancer cells to 5T4-specific T cells. The aim was to establish which immunogenic signals are important in radiation-induced cross-presentation. Radiation (12 Gy) caused G2-M cell-cycle arrest and cell death, increased cellular 5T4 levels, high-mobility protein group-B1 (HMGB1) release, and surface calreticulin and heat-shock protein-70 (Hsp70) expression in DU145 cells. DCs phagocytosed irradiated tumor cells efficiently, followed by upregulation of CD86 on phagocytic DCs. CD8(+) 5T4-specific T cells, stimulated with these DCs, proliferated and produced IFNγ. Inhibition of HMGB1 or the TRIF/MyD88 pathway only had a partial effect on T-cell stimulation. Unlike previous investigators, we found no evidence that DCs carrying Asp299Gly Toll-like receptor-4 (TLR4) single-nucleotide polymorphism had impaired ability to cross-present tumor antigen. However, pretreatment of tumor cells with Hsp70 inhibitors resulted in a highly statistically significant and robust prevention of antigen cross-presentation and CD86 upregulation on DCs cocultured with irradiated tumor cells. Blocking the Hsp70 receptor CD91 also abolished cross-presentation. Together, the results from our study demonstrate that irradiation induces immunologically relevant changes in tumor cells, which can trigger CD8(+) T-cell responses via a predominantly Hsp70-dependent antigen cross-presentation process.©2015 American Association for Cancer Research.
Related Compounds
Related Articles:
2014-12-01
[Tissue Eng. Part A 20(23-24) , 3163-75, (2014)]
2015-02-04
[J. Neurosci. 35(5) , 1999-2014, (2015)]
2014-12-01
[Biochem. Pharmacol. 92(3) , 467-75, (2014)]
2014-12-01
[J. Virol. 88(23) , 13669-77, (2014)]
Hypoxia reduces MAX expression in endothelial cells by unproductive splicing.
2014-12-20
[FEBS Lett. 588(24) , 4784-90, (2014)]